天成國際(00109.HK):陳傳進辭任執行董事及董事會主席職務
格隆匯 4 月 30日丨天成國際(00109.HK)公吿,由於陳傳進有意投放更多時間尋求其他事業發展,故陳傳進已辭任(i)執行董事;(ii)董事會主席;(iii)董事會提名委員會主席及成員;及(iv)香港聯合交易所有限公司證券上市規則第3.05條下的授權代表,自2021年4月30日起生效。
獨立非執行董事兼提名委員會的現任成員周安達源獲委任為提名委員會主席以代替陳傳進。
於陳傳進辭任上市規則第3.05條規定的公司的授權代表後,執行董事劉斌已獲委任為授權代表。於上述變動後,劉斌及關山將為公司的授權代表。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.